3.5. Neutralizing IL-15 Protects Nlrp3−/− from Intestinal Inflammation and Damage in the DSS Model of Colitis, an Effect That Is Associated with Reduced Colonic IL-17. This evidence concerns the gene NLRP3 and colitis.